Celera Corporation
1401 Harbor Bay Parkway
Alameda,
CA 94502
United States - Map
Phone: 510-749-4200
Web Site: http://www.celera.com
| Celera Corporation delivers personalized disease management through a combination of products and services. It operates in three segments: Lab Services, Products, and Corporate. The Lab Services segment offers clinical laboratory tests and disease management services for healthcare providers to enhance cardiovascular disease treatment regimens for patients. It offers clinical laboratory testing services that characterize and monitor cardiovascular disease risk, and personalized treatment and ongoing therapeutic compliance education services. The principal tests offered by this segment include LDL-S3GGE test that measures low-density lipoprotein (LDL) size as a subclass distribution divided in seven regions and characterizes the amount of LDL distributed in these regions; HDL-S10GGE test that measures high-density lipoprotein (HDL) size as a subclass distribution divided across five HDL regions and characterizes the amount of HDL distributed in these regions; Apolipoprotein E Genotypes test for lipoprotein metabolism; and Kinesin-Like Protein 6 test, which detects a variant in a gene called Kinesin-Like Protein 6. The Products segment develops and manufactures molecular diagnostic products for disease detection, prediction of disease predisposition, monitoring of disease progression and disease severity, and determination of patient responsiveness to treatments. It has a strategic alliance with Abbott Laboratories to discover, develop, and commercialize molecular diagnostic products for disease detection, prediction of disease predisposition, disease progression monitoring, and therapy selection. The Corporate segment licenses small molecule drug development programs and Life TechnologiesÂ’ intellectual property to third parties for use in the diagnostic field; and establishes collaborations to develop cancer therapies based on its proteomics discoveries. The company was founded in 1998 and is headquartered in Alameda, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Ms. Kathy Ordonez , 57
Chief Exec. Officer, Pres, Director and Pres of Celera Genomics Group |
$
1.32M |
$
0 | Dr. Thomas J. White Ph.d., 63
Chief Scientific Officer and Sr. VP of Research |
$
630.00K |
$
0 | Mr. Michael A. Zoccoli Ph.D, 58
Sr. VP of Products Group |
$
423.00K |
$
0 | Mr. Paul D. Arata , 54
Sr. VP of HR and Admin. |
$
235.00K |
$
0 | Dr. Stacey R. Sias Ph.D., 55
Sr. VP of Bus. Devel. & Strategic Planning |
$
459.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
Profile
